지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2008.2
- 수록면
- 91 - 97 (7page)
이용수
초록· 키워드
오류제보하기
Purpose: Hurthle cell carcinoma (HCC) of the thyroid gland is a rare disease that represents 3% of all thyroid carcinomas. HCC has been known as a more aggressive disease than the usual differentiated thyroid carcinoma. However, the biologic behavior and optimal treatment have come under considerable debate in recent years. This study was performed to evaluate the clinicopathologic features and treatment outcome of HCC.
Methods: From April 1986 to August 2006, 18 patients with HCC and 216 patients with pure follicular carcinoma (PFC) underwent thyroidectomy at our institutions with a mean follow-up of 114 (range: 6∼253) months. The clinicopathologic characteristics and treatment outcome of each group were compared, and the prognostic factors for disease-free survival were analyzed.
Results: There were 14 women and 4 men with a mean age of 50 (range: 26∼76) years. Compared with PFC patients, all of clinicopathologic features of HCC patients were different (gender, age, tumor size, multifocality, angioinvaion, invasion to adjacent structures, the subclassification and initial distant metastasis), but the high incidence of bilaterality was similar to the PFC patients (P＜0.0001). The causespecific survival (CSS) rates at 10 years were 83.4% in the HCC patients and 89.3% in the PFC patients (P=0.702). Older age (greater than 45) (P=0.0125) and initial distant metastasis (P＜0.0001) in the HCC patients, and an older age (P＜0.0001), male gender (P=0.0039), angioinvasion (P= 0.0122), invasion to adjacent structures (P＜0.0001), a widely invasive type (P=0.004) and initial distant metastasis (P＜0.0001) in the PCC patients were independent prognostic factors for survival.
Conclusion: After accounting for important biologic behaviors, patients with HCC had similar clinicopathologic characteristics and prognosis compared with that of the PFC patients. Therefore, HCC should be managed using the same treatment strategy as PFC.
Methods: From April 1986 to August 2006, 18 patients with HCC and 216 patients with pure follicular carcinoma (PFC) underwent thyroidectomy at our institutions with a mean follow-up of 114 (range: 6∼253) months. The clinicopathologic characteristics and treatment outcome of each group were compared, and the prognostic factors for disease-free survival were analyzed.
Results: There were 14 women and 4 men with a mean age of 50 (range: 26∼76) years. Compared with PFC patients, all of clinicopathologic features of HCC patients were different (gender, age, tumor size, multifocality, angioinvaion, invasion to adjacent structures, the subclassification and initial distant metastasis), but the high incidence of bilaterality was similar to the PFC patients (P＜0.0001). The causespecific survival (CSS) rates at 10 years were 83.4% in the HCC patients and 89.3% in the PFC patients (P=0.702). Older age (greater than 45) (P=0.0125) and initial distant metastasis (P＜0.0001) in the HCC patients, and an older age (P＜0.0001), male gender (P=0.0039), angioinvasion (P= 0.0122), invasion to adjacent structures (P＜0.0001), a widely invasive type (P=0.004) and initial distant metastasis (P＜0.0001) in the PCC patients were independent prognostic factors for survival.
Conclusion: After accounting for important biologic behaviors, patients with HCC had similar clinicopathologic characteristics and prognosis compared with that of the PFC patients. Therefore, HCC should be managed using the same treatment strategy as PFC.
목차
서론
방법
결과
고찰
결론
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
조기 간세포암종의 임상 및 병리학적 특성
Journal of Pathology and Translational Medicine
2004 .01
-
S100A14 Promotes the Growth and Metastasis of Hepatocellular Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2013 .01
-
Differentiated Thyroid Carcinoma in Patients Less than 20 Years of Age at Diagnosis : Clinicopathologic Characteristics and Prognostic Factors
대한두경부종양학회 학술대회
2005 .01
-
Outcome of Hepatectomy for Huge Hepatocellular Carcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2011 .06
-
High Prevalence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Thailand
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
갑상선 여포암의 예후인자 및 치료
Annals of Surgical Treatment and Research
2010 .03
-
[Free Paper] Clinicopathologic characteristics of male patients with papillary thyroid carcinoma
대한외과학회 학술대회 초록집
2011 .11
-
Sigmoid colon metastasis from hepatocellular carcinoma
Clinical and Molecular Hepatology
2010 .01
-
Advances in Management of Hepatocellular Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Survival-Related Factors of Spinal Metastasis with Hepatocellular Carcinoma in Current Surgical Treatment Modalities : A Single Institute Experience
대한신경외과학회지
2015 .01
-
간세포암종 치료의 최신 지견
대한내과학회지
2009 .01
-
Clinicopathological characteristics and prognostic factors in combined hepatocellular carcinoma and cholangiocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2013 .11
-
Is Hepatectomy for Huge Hepatocellular Carcinoma (≥10cm in Diameter) Safe and Effective? A Single-center Experience
Asian Pacific journal of cancer prevention : APJCP
2014 .01
-
Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Clinical and Molecular Hepatology
2019 .01
-
Current Trends and Recent Advances in Diagnosis, Therapy, and Prevention of Hepatocellular Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
갑상선에서 발생한 소세포암 2예
대한내과학회지
2009 .01
-
3개월 이내에 갑자기 발생한 거대 간세포암종
영남의대학술지
2012 .01
-
Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
Clinical and Molecular Hepatology
2020 .01
-
갑상선 여포암의 임상양상과 고찰
대한이비인후-두경부외과학회지
2010 .01
-
Hepatocellular carcinoma during pregnancy : Is HCC in pregnant patient more aggressive?
대한외과학회 학술대회 초록집
2009 .11
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2013-514-002693550